Glucagon-like peptide-1 (GLP-1) inhibitors have proven effective in preventing cardiovascular events, leading to experts ...

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...

Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival ...

A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

A day or so after the 30-year-old middle school English teacher and mother took her first injection of compounded tirzepatide, Smith had plans to go to Olive Garden with her coworkers. Smith ordered ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, ...

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...